<p>Described herein are compounds, pharmaceutical compositions and methods for the inhibition of RAF kinae mediated signaling. Said compounds, pharmaceutical compositions and methods have utility in the treatment of human disease and disorders.</p>
申请公布号
EP2686317(A2)
申请公布日期
2014.01.22
申请号
EP20120758217
申请日期
2012.03.16
申请人
SELEXAGEN THERAPEUTICS, INC.
发明人
VERNIER, JEAN-MICHEL;HOPKINS, STEPHANIE;BOUNAUD, PIERRE-YVES;O'CONNOR, PATRICK;MATTHEWS, DAVID;BENDER, STEVE